BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Adenylyl Imidodiphosphate

An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.

300+ PubMed studies analyzed · Evidence Score: 43.1

Research Domains

Adenylyl Imidodiphosphate has been studied across 15 research domains including ⚡ Energy & Fatigue, 🦴 Bone & Joint, 🧠 Focus & Attention, 💪 Strength & Power, 🫁 Liver & Detox. The primary research focus is ⚡ Energy & Fatigue with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Adenylyl Imidodiphosphate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Clotrimazole
2 shared targets
myricetin-3-O-galactopyranoside
2 shared targets
Quercetin
2 shared targets
magnolia
2 shared targets
rheum
2 shared targets
molibresib
2 shared targets
pulsatilla
3 shared targets
bletilla
2 shared targets
lithospermum
4 shared targets
hirudo
4 shared targets
Loading evidence profile...

This evidence profile for Adenylyl Imidodiphosphate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.